Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Licht-Mayer

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Neuroscience Letters|May 15, 2019
Targeting mitochondria to protect axons in progressive MSGraham Campbell, Simon Licht-Mayer, Don Mahad
Acta Neuropathologica|June 20, 2015
Cell type-specific Nrf2 expression in multiple sclerosis lesionsSimon Licht-Mayer, Isabella Wimmer, Sarah Traffehn, et al.
Science Translational Medicine|August 31, 2022
Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancerShane J F Cronin, Shuan Rao, Miguel A Tejada, et al.
Nature Metabolism|July 10, 2023
Targeting the TCA cycle can ameliorate widespread axonal energy deficiency in neuroinflammatory lesionsYi-Heng Tai, Daniel Engels, Giuseppe Locatelli, et al.
Neuropathology and Applied Neurobiology|October 1, 2022
Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosisSimon Licht-Mayer, Graham R Campbell, Arpan R Mehta, et al.
Acta Neuropathologica|June 24, 2020
Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosisSimon Licht-Mayer, Graham R Campbell, Marco Canizares, et al.
Biorxiv : the Preprint Server for Biology|May 22, 2023
Crucial neuroprotective roles of the metabolite BH4 in dopaminergic neuronsShane J F Cronin, Weonjin Yu, Ashley Hale, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Neuroscience Letters|May 15, 2019
Targeting mitochondria to protect axons in progressive MSGraham Campbell, Simon Licht-Mayer, Don Mahad
Acta Neuropathologica|June 20, 2015
Cell type-specific Nrf2 expression in multiple sclerosis lesionsSimon Licht-Mayer, Isabella Wimmer, Sarah Traffehn, et al.
Science Translational Medicine|August 31, 2022
Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancerShane J F Cronin, Shuan Rao, Miguel A Tejada, et al.
Nature Metabolism|July 10, 2023
Targeting the TCA cycle can ameliorate widespread axonal energy deficiency in neuroinflammatory lesionsYi-Heng Tai, Daniel Engels, Giuseppe Locatelli, et al.
Neuropathology and Applied Neurobiology|October 1, 2022
Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosisSimon Licht-Mayer, Graham R Campbell, Arpan R Mehta, et al.
Acta Neuropathologica|June 24, 2020
Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosisSimon Licht-Mayer, Graham R Campbell, Marco Canizares, et al.
Biorxiv : the Preprint Server for Biology|May 22, 2023
Crucial neuroprotective roles of the metabolite BH4 in dopaminergic neuronsShane J F Cronin, Weonjin Yu, Ashley Hale, et al.
Pageof 1